These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 33893760)

  • 1. Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy.
    Copur M
    Oncology (Williston Park); 2021 Apr; 35(4):190-198. PubMed ID: 33893760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-Based Vaccines in Cancer Immunotherapy.
    McNamara MA; Nair SK; Holl EK
    J Immunol Res; 2015; 2015():794528. PubMed ID: 26665011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: mRNA Vaccines and Immunotherapy in Oncology: A New Era for Personalized Medicine.
    Parums DV
    Med Sci Monit; 2021 May; 27():e933088. PubMed ID: 33994538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future in an RNA molecule: from mRNA vaccines to therapeutics - An interview with Drew Weissman.
    Ruffell D
    FEBS Lett; 2021 Sep; 595(18):2305-2309. PubMed ID: 34549422
    [No Abstract]   [Full Text] [Related]  

  • 6. mRNA vaccine for cancer immunotherapy.
    Miao L; Zhang Y; Huang L
    Mol Cancer; 2021 Feb; 20(1):41. PubMed ID: 33632261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA vaccine development and applications: A special focus on tumors (Review).
    Chen B; Yang Y; Wang X; Yang W; Lu Y; Wang D; Zhuo E; Tang Y; Su J; Tang G; Shao S; Gu K
    Int J Oncol; 2024 Aug; 65(2):. PubMed ID: 38994758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA vaccines: a new era in vaccine development.
    Chandra S; Wilson JC; Good D; Wei MQ
    Oncol Res; 2024; 32(10):1543-1564. PubMed ID: 39308511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunological effects of mRNA vaccines in malignant diseases.
    Heine A; Juranek S; Brossart P
    Mol Cancer; 2021 Mar; 20(1):52. PubMed ID: 33722265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA Cancer Vaccines.
    Fiedler K; Lazzaro S; Lutz J; Rauch S; Heidenreich R
    Recent Results Cancer Res; 2016; 209():61-85. PubMed ID: 28101688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape.
    Chakraborty C; Sharma AR; Bhattacharya M; Lee SS
    Front Immunol; 2021; 12():679344. PubMed ID: 34305909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.
    Li J; Sun Y; Jia T; Zhang R; Zhang K; Wang L
    Int J Cancer; 2014 Apr; 134(7):1683-94. PubMed ID: 24105486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.
    Pascolo S
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33572452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer.
    Sivaganesh V; Promi N; Maher S; Peethambaran B
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Messenger RNA vaccines against SARS-CoV-2.
    Topol EJ
    Cell; 2021 Mar; 184(6):1401. PubMed ID: 33740443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.
    Minnaert AK; Vanluchene H; Verbeke R; Lentacker I; De Smedt SC; Raemdonck K; Sanders NN; Remaut K
    Adv Drug Deliv Rev; 2021 Sep; 176():113900. PubMed ID: 34324884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of Synthetic mRNA Encoding FOXP3 Antigen into Dendritic Cells for Inflammatory Breast Cancer Immunotherapy.
    Devi GR; Nath S
    Methods Mol Biol; 2016; 1428():231-43. PubMed ID: 27236803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to RNA Vaccines Post COVID-19.
    Kramps T
    Methods Mol Biol; 2024; 2786():1-22. PubMed ID: 38814388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer.
    Rausch S; Schwentner C; Stenzl A; Bedke J
    Hum Vaccin Immunother; 2014; 10(11):3146-52. PubMed ID: 25483661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA Cancer Vaccines-Messages that Prevail.
    Grunwitz C; Kranz LM
    Curr Top Microbiol Immunol; 2017; 405():145-164. PubMed ID: 28401358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.